• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4634165)   Today's Articles (40)   Subscriber (49985)
For: Nourparvar A, Bulotta A, Di Mario U, Perfetti R. Novel strategies for the pharmacological management of type 2 diabetes. Trends Pharmacol Sci 2004;25:86-91. [PMID: 15102494 DOI: 10.1016/j.tips.2003.12.007] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Number Cited by Other Article(s)
1
Treviño S, Díaz A, Sánchez-Lara E, Sarmiento-Ortega VE, Flores-Hernández JÁ, Brambila E, Meléndez FJ, González-Vergara E. Pharmacological and Toxicological Threshold of Bisammonium Tetrakis 4-(N,N-Dimethylamino)pyridinium Decavanadate in a Rat Model of Metabolic Syndrome and Insulin Resistance. Bioinorg Chem Appl 2018;2018:2151079. [PMID: 30026756 PMCID: PMC6031092 DOI: 10.1155/2018/2151079] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2018] [Revised: 04/06/2018] [Accepted: 04/18/2018] [Indexed: 01/02/2023]  Open
2
Donnier-Maréchal M, Vidal S. Glycogen phosphorylase inhibitors: a patent review (2013 - 2015). Expert Opin Ther Pat 2016;26:199-212. [PMID: 26666989 DOI: 10.1517/13543776.2016.1131268] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
3
Goyard D, Baron M, Skourti PV, Chajistamatiou AS, Docsa T, Gergely P, Chrysina ED, Praly JP, Vidal S. Synthesis of 1,2,3-triazoles from xylosyl and 5-thioxylosyl azides: evaluation of the xylose scaffold for the design of potential glycogen phosphorylase inhibitors. Carbohydr Res 2012;364:28-40. [DOI: 10.1016/j.carres.2012.09.020] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2012] [Revised: 09/24/2012] [Accepted: 09/26/2012] [Indexed: 10/27/2022]
4
Contreras VU, Meneses-Nava MA, Ornelas-Soto N, Barbosa-García O, López-de-Alba PL, Maldonado JL, Ramos-Ortiz G, Acevedo-Aguilar FJ, López-Martínez L. Fast and environmentally friendly quantitative analysis of active agents in anti-diabetic tablets by an alternative laser-induced breakdown spectroscopy (LIBS) method and comparison to a validated reversed-phase high-performance liquid chromatography (RP-HPLC) method. APPLIED SPECTROSCOPY 2012;66:1294-1301. [PMID: 23146185 DOI: 10.1366/12-06724] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
5
GC Determination of Famotidine, Ranitidine, Cimetidine, and Metformin in Pharmaceutical Preparations and Serum Using Methylglyoxal as Derivatizing Reagent. Chromatographia 2012. [DOI: 10.1007/s10337-012-2321-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
6
Tricarico D, Rolland JF, Cannone G, Mele A, Cippone V, Laghezza A, Carbonara G, Fracchiolla G, Tortorella P, Loiodice F, Conte Camerino D. Structural nucleotide analogs are potent activators/inhibitors of pancreatic β cell KATP channels: an emerging mechanism supporting their use as antidiabetic drugs. J Pharmacol Exp Ther 2011;340:266-76. [PMID: 22028392 DOI: 10.1124/jpet.111.185835] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]  Open
7
Shen DM, Brady EJ, Candelore MR, Dallas-Yang Q, Ding VDH, Feeney WP, Jiang G, McCann ME, Mock S, Qureshi SA, Saperstein R, Shen X, Tong X, Tota LM, Wright MJ, Yang X, Zheng S, Chapman KT, Zhang BB, Tata JR, Parmee ER. Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core. Bioorg Med Chem Lett 2010;21:76-81. [PMID: 21147532 DOI: 10.1016/j.bmcl.2010.11.074] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2010] [Revised: 11/09/2010] [Accepted: 11/16/2010] [Indexed: 11/19/2022]
8
Tóth M, Kun S, Bokor É, Benltifa M, Tallec G, Vidal S, Docsa T, Gergely P, Somsák L, Praly JP. Synthesis and structure–activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase. Bioorg Med Chem 2009;17:4773-85. [DOI: 10.1016/j.bmc.2009.04.036] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2009] [Revised: 04/15/2009] [Accepted: 04/17/2009] [Indexed: 12/22/2022]
9
Qian F, Ni N, Burton LS, Wang YF, Desikan S, Hussain M, Smith RL. Sustained release subcutaneous delivery of BMS-686117, a GLP-1 receptor peptide agonist, via a zinc adduct. Int J Pharm 2009;374:46-52. [DOI: 10.1016/j.ijpharm.2009.03.007] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2008] [Revised: 03/04/2009] [Accepted: 03/06/2009] [Indexed: 12/01/2022]
10
Misaki N, Mao X, Lin YF, Suga S, Li GH, Liu Q, Chang Y, Wang H, Wakui M, Wu J. Iptakalim, a Vascular ATP-Sensitive Potassium (KATP) Channel Opener, Closes Rat Pancreatic β-Cell KATPChannels and Increases Insulin Release. J Pharmacol Exp Ther 2007;322:871-8. [PMID: 17522344 DOI: 10.1124/jpet.107.121129] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]  Open
11
Roy S, Khanna V, Mittra S, Dhar A, Singh S, Mahajan DC, Priyadarsiny P, Davis JA, Sattigeri J, Saini KS, Bansal VS. Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice. Life Sci 2007;81:72-9. [PMID: 17532347 DOI: 10.1016/j.lfs.2007.04.026] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2007] [Revised: 03/29/2007] [Accepted: 04/23/2007] [Indexed: 01/18/2023]
12
Shukla P, Singh AB, Srivastava AK, Pratap R. Chalcone based aryloxypropanolamines as potential antihyperglycemic agents. Bioorg Med Chem Lett 2007;17:799-802. [PMID: 17095211 DOI: 10.1016/j.bmcl.2006.10.068] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2006] [Revised: 10/09/2006] [Accepted: 10/24/2006] [Indexed: 01/19/2023]
13
Biological activity of vanadium compounds. Open Life Sci 2006. [DOI: 10.2478/s11535-006-0029-z] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]  Open
14
Ahrén B. Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties. Expert Opin Investig Drugs 2006;15:431-42. [PMID: 16548792 DOI: 10.1517/13543784.15.4.431] [Citation(s) in RCA: 67] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
15
Tam J, Diamond J, Maysinger D. Dual-action peptides: a new strategy in the treatment of diabetes-associated neuropathy. Drug Discov Today 2006;11:254-60. [PMID: 16580602 DOI: 10.1016/s1359-6446(05)03722-0] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
16
Shen DM, Zhang F, Brady EJ, Candelore MR, Dallas-Yang Q, Ding VDH, Dragovic J, Feeney WP, Jiang G, McCann PE, Mock S, Qureshi SA, Saperstein R, Shen X, Tamvakopoulos C, Tong X, Tota LM, Wright MJ, Yang X, Zheng S, Chapman KT, Zhang BB, Tata JR, Parmee ER. Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists. Bioorg Med Chem Lett 2005;15:4564-9. [PMID: 16102966 DOI: 10.1016/j.bmcl.2005.06.101] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2005] [Revised: 06/24/2005] [Accepted: 06/29/2005] [Indexed: 11/22/2022]
17
Wick JY. New mechanisms of action provide alternative therapies. THE CONSULTANT PHARMACIST : THE JOURNAL OF THE AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 2005;20:404-10, 413-4. [PMID: 16548638 DOI: 10.4140/tcp.n.2005.404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/07/2023]
18
Ahren B. Exenatide: a novel treatment of Type 2 diabetes. ACTA ACUST UNITED AC 2005. [DOI: 10.1586/14750708.2.2.207] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
19
Ahrén B. Exenatide: a novel treatment of Type 2 diabetes. ACTA ACUST UNITED AC 2005. [DOI: 10.2217/14750708.2.2.207] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
20
Stintzing FC, Carle R. Cactus stems (Opuntia spp.): A review on their chemistry, technology, and uses. Mol Nutr Food Res 2005;49:175-94. [PMID: 15729672 DOI: 10.1002/mnfr.200400071] [Citation(s) in RCA: 201] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA